SCHEMBL10107570

SCHEMBL10107570

CC(C)CN(Cc1ccc2c(c1)OCCCO2)C(=O)C(C)N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TAAR1 Q96RJ0 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
HPGD P15428 3/20 0.39
USP2 O75604 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
ALDH1A1 P00352 3/20 0.39
GAA P10253 2/20 0.39
TSHR P16473 2/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565345 1.00 PROKR2 (0.41) PROKR2MEN1KMT2ATAAR1SLC6A2
SCHEMBL565096 1.00 PROKR2 (0.41) PROKR2MEN1KMT2ATAAR1SLC6A2
SCHEMBL565673 0.88 PROKR2 (0.43) PROKR2MEN1KMT2APTGS1PTGS2
SCHEMBL565373 0.86 TAAR1 (0.41) MEN1KMT2ATAAR1SLC6A2SLC6A4
SCHEMBL565473 0.84 GAA (0.43) PROKR2MEN1KMT2AHPGDLMNA
SCHEMBL565318 0.83 PROKR2 (0.54) PROKR2ALDH1A1HTTRAB9ASMN1; SMN2
SCHEMBL565273 0.83 PROKR2 (0.54) PROKR2ALDH1A1HTTRAB9ASMN1; SMN2
SCHEMBL10106594 0.83 PROKR2 (0.54) PROKR2ALDH1A1HTTRAB9ASMN1; SMN2
SCHEMBL565643 0.81 ALDH1A1 (0.45) PROKR2MEN1KMT2AHPGDUSP2
SCHEMBL10119879 0.81 ALDH1A1 (0.45) PROKR2MEN1KMT2AHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885MEN1 767/4885KMT2A 4644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.